Chemical activators of ALS2CR13 can engage various signaling pathways to enhance the functional activity of this protein. Acetylcholine, through its interaction with cholinergic receptors, initiates a cascade of intracellular events that can lead to the phosphorylation and activation of ALS2CR13. Similarly, Forskolin, by increasing intracellular cAMP, indirectly stimulates the protein kinase A (PKA) pathway, which can lead to the subsequent activation of ALS2CR13. Ionomycin, by increasing intracellular calcium concentrations, can trigger the activation of calcium-dependent protein kinases that may target and phosphorylate ALS2CR13, thereby increasing its activity.
Phorbol 12-myristate 13-acetate (PMA) is a potent activator of protein kinase C (PKC), which, upon activation, can phosphorylate a wide range of substrates, including ALS2CR13. Epidermal Growth Factor (EGF) binds to its receptor and activates downstream signaling cascades that are known to involve phosphorylation events, which can result in the functional activation of ALS2CR13. Bradykinin, by interacting with its G-protein-coupled receptors, and Histamine, through its own set of receptors, both initiate signaling events that can culminate in the activation of ALS2CR13. Glutamate acts through its receptors to begin signaling processes that can include the activation of ALS2CR13 as part of their broader effects on neuronal function. Insulin, by engaging its receptor, initiates a well-characterized signaling pathway that can lead to the activation of various cellular proteins, among which ALS2CR13 can be activated as a downstream effector. Hydrogen Peroxide, as a reactive oxygen species, can activate signaling pathways involving ALS2CR13, while Nitric Oxide Donor (SNAP) releases nitric oxide that activates guanylate cyclase, increasing cGMP levels and potentially leading to ALS2CR13 activation. Lastly, Lithium Chloride, through its inhibition of glycogen synthase kinase 3 (GSK-3), can lead to the activation of ALS2CR13 as a part of its impact on cellular signaling pathways.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Forskolin activates adenylate cyclase, increasing cAMP levels, which in turn can activate protein kinase A (PKA) and downstream proteins including ALS2CR13. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $76.00 $265.00 | 80 | |
Ionomycin is a calcium ionophore that raises intracellular calcium levels, which can activate calcium-dependent protein kinases that phosphorylate and activate ALS2CR13. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
PMA activates protein kinase C (PKC) which can then phosphorylate and enhance the activity of ALS2CR13. | ||||||
Bradykinin | 58-82-2 | sc-507311 | 5 mg | $110.00 | ||
Bradykinin can engage G-protein-coupled receptors, triggering signaling cascades that may include ALS2CR13 activation. | ||||||
Histamine, free base | 51-45-6 | sc-204000 sc-204000A sc-204000B | 1 g 5 g 25 g | $92.00 $277.00 $969.00 | 7 | |
Histamine, through its receptors, can activate intracellular signaling pathways including those involving ALS2CR13. | ||||||
L-Glutamic Acid | 56-86-0 | sc-394004 sc-394004A | 10 g 100 g | $291.00 $566.00 | ||
As a neurotransmitter, Glutamate can activate specific receptors leading to intracellular signaling cascades that could involve the activation of ALS2CR13. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $153.00 $1224.00 $12239.00 | 82 | |
Insulin can activate insulin receptor signaling pathways that can lead to the activation of downstream proteins including ALS2CR13. | ||||||
Hydrogen Peroxide | 7722-84-1 | sc-203336 sc-203336A sc-203336B | 100 ml 500 ml 3.8 L | $30.00 $60.00 $93.00 | 27 | |
As a reactive oxygen species, Hydrogen Peroxide can act as a signaling molecule to activate pathways that include ALS2CR13. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium ions can inhibit glycogen synthase kinase 3 (GSK-3), which may result in the activation of signaling pathways involving ALS2CR13. | ||||||